Ecully, France · Founded 2003 · Privately Held (backing)
Manufacturer of pharmaceutical ingredients and specialty ingredients based in Ecully, France. Seqens is based in Ecully, France and was founded in 2003. Its last reported valuation was $1.6 billion in Nov 2022. It has raised $544 million.
Last reported valuation
$1.6B
Oct 2026
Priced at
—
Total raised
$543.8M
Last round
—
Cap table — not yet on record
Seqens's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Seqens with a free account
·Watch Seqens: the Monday email on marks, rounds and moves
